Cargando…
Baricitinib for patients with severe COVID-19—time to change the standard of care?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813061/ https://www.ncbi.nlm.nih.gov/pubmed/35123659 http://dx.doi.org/10.1016/S2213-2600(22)00021-2 |
| _version_ | 1784644782686994432 |
|---|---|
| author | Supady, Alexander Zeiser, Robert |
| author_facet | Supady, Alexander Zeiser, Robert |
| author_sort | Supady, Alexander |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8813061 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88130612022-02-04 Baricitinib for patients with severe COVID-19—time to change the standard of care? Supady, Alexander Zeiser, Robert Lancet Respir Med Comment Elsevier Ltd. 2022-04 2022-02-03 /pmc/articles/PMC8813061/ /pubmed/35123659 http://dx.doi.org/10.1016/S2213-2600(22)00021-2 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Supady, Alexander Zeiser, Robert Baricitinib for patients with severe COVID-19—time to change the standard of care? |
| title | Baricitinib for patients with severe COVID-19—time to change the standard of care? |
| title_full | Baricitinib for patients with severe COVID-19—time to change the standard of care? |
| title_fullStr | Baricitinib for patients with severe COVID-19—time to change the standard of care? |
| title_full_unstemmed | Baricitinib for patients with severe COVID-19—time to change the standard of care? |
| title_short | Baricitinib for patients with severe COVID-19—time to change the standard of care? |
| title_sort | baricitinib for patients with severe covid-19—time to change the standard of care? |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813061/ https://www.ncbi.nlm.nih.gov/pubmed/35123659 http://dx.doi.org/10.1016/S2213-2600(22)00021-2 |
| work_keys_str_mv | AT supadyalexander baricitinibforpatientswithseverecovid19timetochangethestandardofcare AT zeiserrobert baricitinibforpatientswithseverecovid19timetochangethestandardofcare |